Endocrine-Related Cancer

Papers
(The H4-Index of Endocrine-Related Cancer is 24. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-01-01 to 2026-01-01.)
ArticleCitations
Acknowledgement to reviewers115
Survival following resection of 10,244 lung neuroendocrine tumours: a population study96
Refining long-term surveillance requirements in patients with differentiated thyroid cancer69
ERRATUM: Roles of the HOXA10 gene during castrate-resistant prostate cancer progression52
Defining aging-associated factors that increase susceptibility to prostate cancer49
Chemokines with CXC motif and their receptors in neuroendocrine neoplasms49
Acknowledgement to reviewers48
Spironolactone is associated with reduced mitotane levels in adrenocortical carcinoma patients35
Prognostic of recurrence and survival in poorly differentiated thyroid cancer35
Deregulated kinase action in prostate cancer: molecular basis and therapeutic implications34
Identifying metastatic renal cell carcinoma in thyroid fine-needle aspirates by molecular testing34
Сytotoxic T lymphocyte-associated protein 4 (CTLA4) is overexpressed in a subset of prolactin- and growth hormone-secreting pituitary adenomas34
ERRATUM: Pegvisomant and pasireotide in PRL and GH co-secreting vs GH-secreting Pit-NETs31
Clinical presentation of bone metastases in neuroendocrine tumors: a retrospective cohort study30
Update on the genetics of paragangliomas28
Interleukin-6 promotes the dedifferentiation of papillary thyroid cancer cells28
Targeting growth hormone in cancer: future perspectives27
Metastatic neuroendocrine neoplasms of the breast: a systematic review26
Differential activity of specific inhibitors of transcription regulating cyclin-dependent kinases in thyroid cancer cells26
Radiation reprograms fibroblasts to drive prostate cancer therapy resistance26
Peptide receptor radionuclide therapy in malignant insulinoma25
FAM64A contributes to ovarian cancer proliferation and metastasis by suppressing TWIST1 ubiquitination and degradation25
CORRIGENDUM: GPER1 is regulated by insulin in cancer cells and cancer-associated fibroblasts24
The genetic changes in 11p15.5-related pheochromocytomas and paragangliomas24
0.32582902908325